Dow Up 1.53% Nasdaq Up 1.70%

Impax Laboratories Inc. (IPXL)

-NasdaqGS
27.73 Up 0.64(2.36%) 12:33PM EDT - Nasdaq Real Time Price
Prev Close:27.09
Open:27.38
Bid:27.79 x 400
Ask:27.81 x 200
1y Target Est:30.31
Beta:1.34
Next Earnings Date: 4-Nov-14IPXL Earnings announcement
Day's Range:27.11 - 27.98
52wk Range:19.67 - 31.04
Volume:276,016
Avg Vol (3m):744,074
Market Cap:1.89B
P/E (ttm):61.08
EPS (ttm):0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IPXLUp 2.36%1.89B
MYLUp 0.66%18.96B
TEVAUp 0.90%45.84B

Key Statistics

Forward P/E (1 yr):37.07
P/S (ttm):3.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :1.19
Quarterly EPS Est (Sep-14) :0.31
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products; and develops and markets branded products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback